>>>>NEWS! Nasdaq: MABXA --- another GHLstockalert
SOURCE: GHLstockalert
<<< Be careful, I'm starting to think GHLstockalert should be renamed to Hypealert.>>>>
Tiny Nasdaq Company Has Breakthrough Technology of Extreme Importance In Prevention, Diagnosis And Treatment Of Cancer, Alzheimer's, Strokes And Heart Attacks, Says GHLstockalert
OCALA, Fla., June 24 /PRNewswire/ -- American Biogenetic Sciences, Inc. (Nasdaq: MABXA - news) was chosen today by GHLstockalert as the most likely small company to emerge with several huge medical breakthroughs.
According to GHLstockalert, this little ''micro-cap'' company already has five extremely important, medically related patents and is engaged in ongoing, feverishly paced research that may save millions of lives. Aggressive research is conducted in their own facility and through its Global Scientific Network with affiliates and collaborators in the U.S., Russia, Europe, Israel and China. Their agreements with related companies could turn out to be enormously profitable.
One such agreement is with New Horizon Diagnostics (NHD) to develop a rapid point-of-care test for the detection of blood clots (Thrombosis) which is the leading cause of death in the U.S. and other developed countries.
NHD develops tests for the Department of Defense for use in Biowarfare Detection Programs and was the principal supplier to the U.S. Army of rapid biodetection tests during the Persian Gulf war. NHD has received research grants from NASA and NHD rapid tests have been used in several NASA space shuttle missions.
Now, as of June 17, American Biogenetic Sciences, Inc. (ABS) has obtained exclusive rights to market NHD's diagnostic tests to the medical community.
ABS has several such alliances with other companies which could prove to be enormously profitable.
GHLstockalert believes American Biogenetic Sciences, Inc. has been almost totally overlooked by investors because all of its remarkable breakthrough achievements have been described in press releases using almost incomprehensible medical jargon.
Bottom line: with their five proprietary patents, global collaborations, strategic partnerships and continuous, almost unbelievably intense research, American Biogenetic Sciences, Inc.
is a major ray of hope for the early detection, prevention and care of several, major, common and lethal diseases.
''Who knows? Maybe they'll crash and burn, but we sure don't think so,'' says a spokesperson at GHLstockalert. ''We think they're an exceptionally good bet.''
''It's a shame, though, that nobody associated with them seems to be able to write a press release in good ol' plain English.''
|
